Actinium Pharmaceuticals (Delaware) Statistics
NYSE: ATNMHealthcareBiotechnologyUSD
1.08+0.01 (+0.93%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Actinium Pharmaceuticals (Delaware) by the numbers
Actinium Pharmaceuticals (Delaware) has a market capitalization of $34.0 million based on 31.44M shares outstanding. Its trailing P/E ratio is 3.0. The stock trades 1.9% above its 50-day average and 4.8% below its 200-day average.
Average daily trading volume is 138.94K shares, or about $150,061 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATNM valuation vs. peer median
| Metric | ATNM | Peer median | Difference |
|---|---|---|---|
| Market cap | $33.96M | $34.17M | -1% |
| Avg. volume | 138.94K | 261.06K | -47% |
Peer median across 8 companies: NNVC, BCTX, ALGS, GRDX, CVM, IBO, NXTC, LITS.
Valuation
- Market cap
- $33.96M
- P/E (TTM)
- 3.00
- EPS (TTM)
- $0.36
- Shares outstanding
- 31.44M
Price and trading
- Previous close
- 1.07
- Open
- 1.09
- Day range
- 1.06 – 1.10
- 52-week range
- 0.735 – 1.74
- 52-week change
- -32.28%
- Beta
- —
- Volume
- 104.87K
- Average volume
- 138.94K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2025
Additional statistics
- Market Cap
- 33.96M
- Pe
- 3.00
- Forward Pe
- -2.06
- Eps
- 0.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.74
- Week52 Low
- 0.74
- Avg Volume
- 138.94K
- Shares Outstanding
- 31.44M
- Ma50
- 1.06
- Ma200
- 1.13
- Earnings Date
- Aug 4, 2025
- Pct From52w High
- -37.93%
- Pct From52w Low
- 46.94%